期刊文献+

多种手术方式在肺癌手术中的疗效探讨 被引量:7

Investigation of effect of different surgeries in the treatment of lung cancer
下载PDF
导出
摘要 目的探究多种手术方式在肺癌手术中的应用效果。方法本次研究96例肺癌患者根据自愿原则均分为研究组与对照组,对照组行传统肺癌手术治疗,研究组则采用行改良后外侧小切口术治疗。对比分析两组疗效。结果研究组患者在开胸时间、切口长度、开胸出血量、关胸时间、术后带管时间、术后引流量、术后住院时间及术后疼痛分级VAS上皆明显优于对照组患者,有统计学意义(P<0.05);研究组患者不良反应发生率也明显低于对照组,有统计学意义(P<0.01)。结论肺癌患者采用改良后外侧小切口术可取得良好效果,值得临床借鉴。 Objective To investigate the application value of different surgeries in the treatment of lung cancer.Methods 96 patients with lung cancer were randomly divided into the study group and the control group.The control group received traditional operation for lung cancer treatment,and the study group was given with modified small lateral incision.Results The improvement of open time,length of incision,thoraci chemorrhage,sternal closure time,postoperative intubation time,postoperative drainage,postoperative hospital stay and postoperative pain grade VAS was more pronounced in the study group than in the control group (P < 0.05).The incidence of adverse reactions was significantly lower in the study group than in the control group (P < 0.01).Conclusion Modified posterolateral small incision surgery has good curative effect in the treatment of patients with lung cancer.
出处 《临床肺科杂志》 2014年第5期886-887,共2页 Journal of Clinical Pulmonary Medicine
关键词 肺癌 手术 改良后外侧小切口 lung cancer operation modified posterolateral small incision
  • 相关文献

参考文献8

二级参考文献38

  • 1张青,付京,高炳趁,傅卫红,唱荣艳.老年人肺癌150例[J].第四军医大学学报,2005,26(4):296-296. 被引量:2
  • 2谭黎杰,王群,徐正浪,徐松涛,郑如恒.肺叶切除几种微创术式比较[J].中华胸心血管外科杂志,2005,21(2):78-79. 被引量:21
  • 3Robert J. McKenna,罗晓阳.肺癌微创治疗新技术现状——胸腔镜在肺癌治疗中的应用[J].中国癌症杂志,2005,15(3):209-212. 被引量:59
  • 4范虹,王群,蒋伟,徐松涛,郭卫刚,冯明祥.改良Muscle-Sparing剖胸切口在治疗周围型肺部肿块中的应用[J].中国临床医学,2005,12(5):799-800. 被引量:3
  • 5Lee HS, Kwon SY, Kim DK,et al. Determinants of diagnostic bronchial washing in peripheral lung cancers [J]. Int J Tuberc Lung Dis,2007;11 (2) :227-32.
  • 6vander Drift MA, vander Wilt L.J, Thunnissen FB, et al. A prospective study of the timing and cost-effectiveness of bronchial washing during bronchoseopy for pulmonary malignant tumors[J]. Chest ,2005 ; 128 ( 1 ) : 394-400.
  • 7Lee HS, Kwon SY, Kim DK, et al. Bronchial washing yield before and after forceps biopsy in patients with endoscopically visible lung cancers [J]. Respirology, 2007 ; 12 ( 2 ) : 277-82.
  • 8Poletti V, Poletti G, Murer B ,et al. Broncho-alveolar lavage in malignancy [J]. Semin Respir Crit Care Med,2007 ; 28 ( 5 ) : 534-45.
  • 9Eric Edell MD, stephen Lam MD, FCCP, et al. Detection and localizationof intraepithelial neoplasia and invasive carcinoma using fluorescence-re- flectance bronchoscopy [J]. AM J Thorac Onco1,2009 ;4 (1) :49-54.
  • 10Luc Thiberville, Mathieu Salaun. Bronchoscopic Advances:On the Way to the Cells[ JJ. Respiration,2010 ;79:441-9.

共引文献18

同被引文献46

  • 1Riaz SP, Luchtenborg M, Coupland VH, et al. Trends in inci- dence of small cell lung cancer and all lung cancer [ J 1- Lung Cancer, 2012, 75(3) : 280 -284.
  • 2Li H, Yang S, Zhang Y, et al. Thoracic recurrent laryngeal lymph node metastases predict cervical node metastases and benefit fromthree--fleld dissection in selected patients with thoracic e- sophageal squamous cell carcinoma[ J]. J Surg Oncol, 2012, 105 : 548 - 552.
  • 3E1-Badrawy MK, Yousef AM, Shaalan D,et al. Matrix metallo- proteinase-9 expression in lung cancer patients and its relation to serum mmp 9 activity, pathologic type, and prognosis[J]. J Bronchology Interv Pulmonol, 2014,21 (4) : 327-334.
  • 4Braicu EI, Chekerov R, Richter R, et al. HE4 expression in plasma correlates with surgical outcome and overall survival in patients with first ovarian cancer relapse[J3. Ann Surg Oncol, 2014,21(3) :955-962.
  • 5Iwahori K, Suzuki H, Kishi Y, et al. Serum HE4 as a diagnos tic and prognostic marker for lung caneer[J]. Tumour Biol, 2012,33(4) : 1141-1149.
  • 6Liang Y, Ma T, Thakur A,et al. Differentially expressed glyco- sylated patterns of alpha-l-antitrypsin as serum biomarkers for the diagnosis of lung caneer[J]. Glycobiology, 2015,25 (3) 331- 40.
  • 7Angioli R,Miranda A,Aloisi A, et al. A critical review on HE4 performance in endometrial cancer: where are we now [J]. Tumour Biol,2014,35(2) :881 887.
  • 8Liu W, Yang J, Chi PD, et al. Evaluating the clinical significance of serum HE4 levels in lung cancer and pulmonary tuberculosis [J]. Int J Tuberc Lung Dis,2013,17(10) :1346 1353.
  • 9Nagy B Jr, Bhattoa HP, Steiber Z, et al. Serum human epididy- mis protein 4 (HE4) as a tumor marker in men with lung canc- er[J]. ClinChem LabMed,2014,52(ll):1639-1648.
  • 10Wang X, Fan Y,Wang J, et al. Evaluating the expression and di agnostic value of human epididymis protein 4 (HE4) in small cell lung cancer[J]. Tumour Biol,2014 ,35(7)6847 6853.

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部